¿Cómo se comparó el EPS reciente de LBTSF con las expectativas?
¿Cómo fue el desempeño de los ingresos de Almirall, S.A. LBTSF en el último trimestre?
¿Cuál es la estimación de ingresos para Almirall, S.A.?
¿Cuál es la puntuación de calidad de ganancias de Almirall, S.A.?
¿Cuándo informa Almirall, S.A. sus ganancias?
¿Cuáles son las ganancias esperadas de Almirall, S.A.?
¿Superó Almirall, S.A. las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$15.47
Precio de apertura
$15.35
Rango del día
$15.35 - $15.35
Rango de 52 semanas
$9.01 - $15.47
Volumen
100
Volumen promedio
175
EPS (TTM)
0.23
Rendimiento de dividendos
--
Cap. de mercado
$3.2B
¿Qué es Almirall SA?
Almirall SA is a global biopharmaceutical company, which is focused on skin health. The company is headquartered in Barcelona, Barcelona and currently employs 2,026 full-time employees. The company went IPO on 2007-04-19. The firm focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The firm's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The firm operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.